DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
AT9283 is an investigational drug.
There have been 5 clinical trials for AT9283. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2010.
The most common disease conditions in clinical trials are Leukemia, Neoplasms, Plasma Cell, and Leukemia, Myeloid. The leading clinical trial sponsors are Cancer Research UK, NCIC Clinical Trials Group, and Astex Pharmaceuticals.
Recent Clinical Trials for AT9283
|AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia||Cancer Research UK||Phase 1|
|A Study of AT9283 in Patients With Relapsed or Refractory Multiple Myeloma||NCIC Clinical Trials Group||Phase 2|
|AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors||Cancer Research UK||Phase 1|